Enzo Biochem (FRA:EZB) Accounts Payable & Accrued Expense : €7.12 Mil (As of Jan. 2024)

View and export this data going back to 1980. Start your Free Trial

What is Enzo Biochem Accounts Payable & Accrued Expense?

Enzo Biochem's quarterly accounts payable & accrued expense declined from Jul. 2023 (€12.52 Mil) to Oct. 2023 (€10.72 Mil) and declined from Oct. 2023 (€10.72 Mil) to Jan. 2024 (€7.12 Mil).

Enzo Biochem's annual accounts payable & accrued expense declined from Jul. 2021 (€14.52 Mil) to Jul. 2022 (€11.01 Mil) but then increased from Jul. 2022 (€11.01 Mil) to Jul. 2023 (€12.52 Mil).

Enzo Biochem Accounts Payable & Accrued Expense Historical Data

The historical data trend for Enzo Biochem's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzo Biochem Accounts Payable & Accrued Expense Chart

Enzo Biochem Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

11.88

14.87

14.52

11.01

12.52

Enzo Biochem Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															23.00	28.40	12.52	10.72	7.12

Enzo Biochem Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Enzo Biochem (FRA:EZB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Enzo Biochem Inc (FRA:EZB) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

NOTV VNRX BIOQ STIM PSNL PRE OCX MDXH TTOO XGN TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN

Traded in Other Exchanges

ENZ:USA

Address

527 Madison Avenue, New York, NY, USA, 10022

Website

https://www.enzo.com

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.

Enzo Biochem (FRA:EZB) Headlines

No Headlines